NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Baxter International Inc. BAX | NYSE

$24.02 $0.54 | 2.30%
SIGNAL:Signal available — unlock to view |2026-08-19 |F&G 34 |RSI 47.8

Company Overview:

Market Cap: $12.42B
Trailing PE: N/A
FWD PE *: 11.4x
Payout Ratio (TTM): —
52-Week Range: $15.73 - $30.00

* Forward PE is based on street estimates.

10 Year BAX Performance Metrics:

Total Return (with DRIP): -41.0% (-5.14% CAGR)
Total Return (no DRIP): -32.0% (-3.78% CAGR)
Share Price: -49.5% (-6.61% CAGR)
Yield on Cost (with DRIP): 0.10%
Total Invested: $10,000
Total Value (with DRIP): $5,899
Total Return $ (with DRIP): -$4,101
Dividend Increase: -92.3% (-22.64% CAGR)
Dividend Yield (FWD): 0.17% ($0.04)
BAX 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
BAX Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
BAX Price CAGR:1Y: 5.49%2Y: -20.46%5Y: -21.47%10Y: -6.61%
BAX Dividend Charts
BAX - Dividends
BAX Dividend CAGR:1Y: -89.71%2Y: -77.73%5Y: -47.09%10Y: -22.16%
BAX - Dividend Payout Ratio
BAX Dividend Payout Ratio CAGR:1Y: -91.70%2Y: 0.00%5Y: -28.21%10Y: 4.32%
BAX - Dividend to Free Cash Flow Ratio
BAX Dividend to FCF Ratio CAGR:1Y: -97.65%2Y: 0.00%5Y: -40.04%10Y: -11.64%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

BAX Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

BAX - Revenue
BAX Revenue CAGR:1Y: 5.34%2Y: -11.88%5Y: -0.91%10Y: 1.36%
BAX - Earnings Per Share (EPS)
BAX EPS CAGR:1Y: 33.33%2Y: 0.00%5Y: -16.46%10Y: -19.84%
BAX - Net Income
🔓 See the full chart40% off right now · 7-day free trial
BAX Net Income CAGR:1Y: 38.46%2Y: 0.00%5Y: -15.82%10Y: -20.26%
BAX - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
BAX EBITDA CAGR:1Y: 3.03%2Y: 54.66%5Y: -6.04%10Y: -9.05%
BAX - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
BAX Free Cash Flow CAGR:1Y: 144.12%2Y: 0.00%5Y: -12.25%10Y: -12.16%
BAX - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
BAX Free Cash Flow / Share CAGR:1Y: -53.31%2Y: 0.00%5Y: -37.21%10Y: -25.06%
BAX - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
BAX Operating Income CAGR:1Y: 13.61%2Y: 0.00%5Y: -12.54%10Y: 12.30%
BAX - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
BAX Gross Profit CAGR:1Y: 4.14%2Y: -15.08%5Y: -3.50%10Y: 0.60%
BAX - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
BAX Shares Outstanding CAGR:1Y: 0.78%2Y: 0.78%5Y: 0.35%10Y: -0.65%
BAX - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
BAX Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BAX - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
BAX Stock-Based Comp CAGR:1Y: -5.71%2Y: -4.26%5Y: -2.26%10Y: 0.63%
BAX - Expenses
🔓 See the full chart40% off right now · 7-day free trial
BAX Expenses CAGR:1Y: -22.15%2Y: -21.66%5Y: -5.99%10Y: -3.64%
BAX - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
BAX - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
BAX - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
BAX - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
BAX - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
BAX - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
BAX - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
BAX Revenue CAGR:1Y: 5.34%2Y: -11.88%5Y: -0.91%10Y: 1.36%
BAX - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
BAX Revenue CAGR:1Y: 5.34%2Y: -11.88%5Y: -0.91%10Y: 1.36%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BAX - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BAX Actual Revenue CAGR:1Y: 5.34%2Y: -11.88%5Y: -0.91%10Y: 1.36%
BAX - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BAX Actual EPS CAGR:1Y: 33.33%2Y: 0.00%5Y: -16.46%10Y: -19.84%
BAX - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BAX Actual Net Income CAGR:1Y: 38.46%2Y: 0.00%5Y: -15.82%10Y: -20.26%
BAX - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
BAX Actual EBITDA CAGR:1Y: 3.03%2Y: 54.66%5Y: -6.04%10Y: -9.05%

Ratios, Profit Margins & Return on Capital:

BAX - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
BAX Net Profit Margin CAGR:1Y: 31.48%2Y: 0.00%5Y: -15.03%10Y: -21.33%
BAX - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
BAX Gross Profit Margin CAGR:1Y: -1.16%2Y: -3.64%5Y: -2.62%10Y: -0.75%
BAX - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
BAX Price to Earnings CAGR:1Y: -47.19%2Y: 0.00%5Y: -8.15%10Y: 15.82%
BAX - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
BAX Price To Sales Ratio CAGR:1Y: -32.64%2Y: -8.24%5Y: -22.21%10Y: -9.02%
BAX - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
BAX Return on Capital Employed CAGR:1Y: 26.99%2Y: 0.00%5Y: -12.39%10Y: 9.22%
BAX - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
BAX Return on Invested Capital CAGR:1Y: 12.48%2Y: 0.00%5Y: -12.75%10Y: 6.50%

Compare stocks side-by-side

BAX Dividends Info:

Annual Dividend: $0.04
Forward Yield: 0.17%
Ex-Dividend Date: 2026-08-28
Lifetime Dividends / Share: $22.60

BAX Dividend History: Dates, Payments & Yield list

Below is a schedule of all BAX dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/28/202610/01/2026$0.0100.15%0.15%$26.00
05/29/202607/01/2026$0.0100.21%0.18%$21.69
02/27/202604/01/2026$0.0100.2%0.24%$16.78
11/28/202501/02/2026$0.0100.21%0.21%$19.50
08/29/202510/01/2025$0.1702.75%2.91%$23.36
05/30/202507/01/2025$0.1702.23%2.18%$31.23
02/28/202504/01/2025$0.1701.97%2%$34.02
11/29/202401/02/2025$0.1702.02%2.32%$29.26
08/30/202410/01/2024$0.2903.06%3.14%$36.91
05/31/202407/01/2024$0.2903.4%3.51%$33.06
02/29/202404/01/2024$0.2902.83%2.66%$43.55
11/30/202301/02/2024$0.2903.22%2.99%$38.85
08/31/202310/02/2023$0.2902.86%3.11%$37.35
06/01/202307/03/2023$0.2902.81%2.6%$44.68
02/23/202304/03/2023$0.2902.86%2.9%$39.98
12/01/202201/03/2023$0.2902.21%2.27%$51.04
09/01/202210/03/2022$0.2902.04%2.09%$55.62
06/02/202207/01/2022$0.2901.56%1.77%$65.49
02/24/202204/01/2022$0.2801.32%1.43%$78.58
12/02/202101/03/2022$0.2801.47%1.29%$86.87
09/02/202110/01/2021$0.2801.38%1.38%$81.29
06/03/202107/01/2021$0.2801.37%1.37%$81.47
02/25/202104/01/2021$0.2451.25%1.16%$84.32
12/03/202001/04/2021$0.2451.28%1.22%$80.12
08/28/202010/01/2020$0.2451.14%1.23%$79.72
06/04/202007/01/2020$0.2451.11%1.12%$87.31
02/27/202004/01/2020$0.2201.04%1.12%$78.66
12/05/201901/02/2020$0.2201.07%1.02%$85.87
08/29/201910/01/2019$0.2201.01%1.02%$85.91
06/06/201907/01/2019$0.2201.15%1.08%$81.43
02/28/201904/01/2019$0.1901.02%0.93%$81.77
11/30/201801/02/2019$0.1901.11%1.16%$65.30
08/30/201810/01/2018$0.1901.03%0.98%$77.80
05/31/201807/02/2018$0.1901.07%1.03%$73.75
03/01/201804/02/2018$0.1600.97%1.01%$63.43
11/30/201701/02/2018$0.1600.98%0.95%$67.17
08/30/201710/02/2017$0.1601.04%1.01%$63.16
05/31/201707/03/2017$0.1601.08%1.06%$60.24
03/01/201704/03/2017$0.1301.02%0.99%$52.29
11/30/201601/03/2017$0.1301.17%1.17%$44.44
08/31/201610/03/2016$0.1301.11%1.09%$47.64
06/01/201607/01/2016$0.1301.2%1.14%$45.45
03/02/201604/01/2016$0.1151.16%1.1%$41.69
12/02/201501/04/2016$0.1151.23%1.24%$37.17
09/02/201510/01/2015$0.1151.23%1.41%$32.73
05/28/201507/01/2015$0.2823.1%2.91%$38.86
03/09/201504/01/2015$0.2823.07%3.08%$36.69
12/03/201401/02/2015$0.2822.82%2.84%$39.82
09/03/201410/01/2014$0.2822.81%2.91%$38.84
06/04/201407/01/2014$0.2822.85%2.82%$40.07
03/05/201404/01/2014$0.2662.89%2.66%$40.02
12/04/201301/03/2014$0.2662.94%2.83%$37.64
09/04/201310/01/2013$0.2662.81%2.99%$35.62
06/05/201307/01/2013$0.2662.85%2.8%$38.06
03/06/201304/01/2013$0.2442.57%2.49%$39.27
12/05/201201/03/2013$0.2442.79%2.66%$36.82
09/05/201210/01/2012$0.2443.1%3%$32.64
06/06/201207/02/2012$0.1822.66%2.49%$29.26
03/07/201204/02/2012$0.1822.33%2.22%$32.73
12/07/201101/04/2012$0.1822.64%2.7%$26.97
09/07/201110/03/2011$0.1682.23%2.31%$29.16
06/08/201107/01/2011$0.1682.15%2.06%$32.72
03/08/201104/01/2011$0.1682.34%2.3%$29.28
12/08/201001/05/2011$0.1682.5%2.45%$27.53
09/08/201010/01/2010$0.1582.7%2.43%$25.88
06/08/201007/01/2010$0.1582.83%2.82%$22.35
03/08/201004/01/2010$0.1581.96%1.99%$31.63
12/08/200901/05/2010$0.1582.1%2%$31.44
09/08/200910/01/2009$0.1411.87%1.87%$30.26
06/08/200907/01/2009$0.1412.24%1.97%$28.65
03/06/200904/01/2009$0.1412%2.05%$27.52
12/08/200801/06/2009$0.1411.99%1.93%$29.31
09/08/200810/01/2008$0.1181.28%1.31%$36.25
06/06/200807/01/2008$0.1181.43%1.36%$34.90
03/06/200804/01/2008$0.1181.52%1.45%$32.59
12/06/200701/03/2008$0.1181.47%1.49%$31.84
09/06/200710/01/2007$0.0910.31%0.3%$30.76
06/06/200707/02/2007$0.0910.29%0.29%$31.40
03/07/200704/02/2007$0.0910.34%0.32%$28.68
12/06/200601/05/2007$0.3161.3%1.24%$25.42
12/07/200501/05/2006$0.3161.49%1.51%$20.94
12/08/200401/05/2005$0.3161.81%1.67%$18.97
12/10/200301/05/2004$0.3161.97%1.92%$16.46
12/11/200201/06/2003$0.3162.02%1.99%$15.92
12/12/200101/07/2002$0.3164.58%4.44%$28.50
12/13/200001/08/2001$0.3165.47%5.48%$23.09
04/03/200004/05/2000$0.73717.45%17.54%$16.80
12/08/199901/03/2000$0.0791.86%1.9%$16.67
09/22/199910/01/1999$0.0791.89%1.9%$16.60
06/09/199907/01/1999$0.0791.73%1.97%$15.96
03/10/199904/01/1999$0.0791.59%1.75%$18.01
12/09/199801/04/1999$0.0791.84%1.84%$17.16
09/08/199810/01/1998$0.0791.97%2.02%$15.60
06/09/199807/01/1998$0.0792.12%2.14%$14.73
03/10/199804/01/1998$0.0792.05%2.11%$14.95
12/08/199701/02/1998$0.0792.26%2.31%$13.61
09/08/199710/01/1997$0.0772.07%2.12%$14.43
06/09/199707/01/1997$0.0772.09%2.01%$15.26
03/06/199704/01/1997$0.0822.58%2.75%$11.92
12/09/199601/02/1997$0.0772.71%2.79%$11.03
10/01/199610/03/1996$0.97832.35%31.82%$12.29
09/09/199610/01/1996$0.0822.68%2.71%$12.09
06/10/199607/01/1996$0.0822.65%2.53%$12.97
03/11/199604/01/1996$0.0772.47%2.47%$12.39
12/11/199501/02/1996$0.0772.75%2.71%$11.30
09/11/199510/02/1995$0.0772.96%2.78%$11.03
06/12/199507/03/1995$0.0773.29%3.13%$9.79
03/09/199504/03/1995$0.0713.38%3.18%$8.96
12/01/199412/05/1994$0.0714.09%4.13%$6.89
08/31/199410/03/1994$0.0713.69%3.75%$7.60
06/02/199407/01/1994$0.0683.85%3.77%$7.20
03/03/199404/01/1994$0.0684.45%4.54%$5.98
12/02/199301/04/1994$0.0684.28%4.08%$6.65
09/01/199310/01/1993$0.0683.71%4.45%$6.11
06/03/199307/01/1993$0.0683.36%3.51%$7.74
03/04/199304/01/1993$0.0683.43%3.4%$7.98
12/03/199201/04/1993$0.0582.56%2.7%$8.66
09/02/199210/01/1992$0.0532.37%2.67%$7.96
06/04/199207/01/1992$0.0532.32%2.32%$9.13
03/05/199204/01/1992$0.0532.44%2.34%$9.07
12/05/199101/02/1992$0.0462.01%1.89%$9.68
09/05/199110/01/1991$0.0462.1%2.21%$8.26
06/06/199107/01/1991$0.0462.23%2.26%$8.08
03/07/199104/01/1991$0.0462.29%2.24%$8.14
12/06/199001/02/1991$0.0392.25%2.34%$6.75
09/06/199010/01/1990$0.0392.72%2.56%$6.17
06/07/199007/02/1990$0.0392.72%2.67%$5.92
03/08/199004/02/1990$0.0392.57%2.67%$5.92
12/07/198901/02/1990$0.0352.24%2.2%$6.29
09/07/198910/02/1989$0.0352.45%2.38%$5.80
06/08/198907/03/1989$0.0352.68%2.67%$5.18
03/09/198904/03/1989$0.0352.91%2.87%$4.81
12/06/198801/03/1989$0.0312.8%2.84%$4.35
09/06/198810/03/1988$0.0312.41%2.85%$4.32
06/07/198807/01/1988$0.0312.28%2.45%$5.03
03/08/198804/01/1988$0.0311.96%2.23%$5.52
12/08/198701/04/1988$0.0271.92%1.88%$5.77
09/08/198710/01/1987$0.0271.67%1.53%$7.09
06/09/198707/01/1987$0.0271.89%1.82%$5.95
03/10/198704/01/1987$0.0271.78%1.84%$5.89
12/09/198601/02/1987$0.0251.97%2.1%$4.69
09/09/198610/01/1986$0.0252.32%2.42%$4.07
06/10/198607/01/1986$0.0252.05%2.16%$4.56
03/11/198604/01/1986$0.0252.24%2.21%$4.47
12/09/198501/02/1986$0.0232.38%2.38%$3.82
09/09/198510/01/1985$0.0232.54%2.78%$3.27
06/04/198507/01/1985$0.0232.43%2.32%$3.92
03/13/198504/01/1985$0.0232.47%2.28%$3.98
12/03/198401/02/1985$0.0202.71%2.5%$3.24
08/31/198410/01/1984$0.0201.96%2.32%$3.48
06/05/198407/02/1984$0.0202.1%2.15%$3.76
03/14/198404/02/1984$0.0201.9%1.97%$4.10
12/05/198301/02/1984$0.0170%1.27%$5.43
09/02/198310/03/1983$0.0170%1.27%$5.43
06/07/198307/01/1983$0.0170%1.27%$5.43
03/16/198303/18/1983$0.0170%1.27%$5.43
12/06/198212/08/1982$0.0140%1.04%$5.43
09/03/198209/08/1982$0.0140%1.04%$5.43
06/07/198206/09/1982$0.0140%1.04%$5.43
03/10/198203/12/1982$0.0140%1.04%$5.43

Projected Future Returns & Dividends for BAX

Based on past 10-year performance, here are BAX growth metrics:

Share price CAGR of -6.61%
Dividend CAGR of -22.64%

Using BAX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BAX (DRIP)BAX - No DRIP
Current Price$24.02$24.02
Start Shares416.32416.32
Start Value$10,000$10,000
  
After 10 years:
Final Share Count419.76416.32
Dividends Payment$0.00$0.00
Annual Dividends$1$1
Yield on cost0.01%0.01%
Share Price$12.12$12.12
Total Dividends$68$68
Final Value$5,088$5,114

Estimated Future Value + Dividends - BAX

NOTE: Above numbers are our estimate based on BAX's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Baxter International Inc. (BAX) had its IPO on 1981-10-27, and is traded on NYSE stock exchange.

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.

BAX website: https://www.baxter.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — BAX

Value from:
Pay up to today
—
vs current price $24.02
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →